Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MilliporeSigma™ Calbiochem™ LFM-A13

Catalog No. 4353005MG Shop All MilliporeSigma Products
Change view
Click to view available options
Quantity:
5 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
43-530-05MG 5 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 43-530-05MG Supplier MilliporeSigma™ Supplier No. 4353005MG
Only null left
Add to Cart
Add to Cart

A potent, cell-permeable, reversible, substrate competitive, and specific inhibitor of Bruton's Tyrosine Kinase (BTK; IC50 = 17.2μM for human BTK

A potent, cell-permeable, reversible, substrate competitive, and specific inhibitor of Bruton’s Tyrosine Kinase (BTK; IC50 = 17.2μM for human BTK in vitro and IC50 = 2.5μM for recombinant BTK). Also inhibits Polo-like kinase in an ATP-competitive manner (IC50 = 10μM and 61μM for Plx1 and Plk3, respectively), and displays antitumor properties. Does not affect the enzymatic activity of other protein tyrosine kinases, including EGFR, HCK, IRK JAK1, and JAK3 even at concentrations of 278μM. Enhances the chemosensitivity of BTK-positive B-lineage leukemia cells to ceramide- and vincristine-induced apoptosis.
TRUSTED_SUSTAINABILITY

Specifications

Color Light Brown
Description 97% by HPLC
Target Proteins Human Bruton's Tyrosine Kinase (BTK)
CAS 62004-35-7
Molecular Formula C11H8Br2N2O2
Formula Weight 360g/mol
Solubility DMSO
Content And Storage Protect from light
Form Solid
Quantity 5 mg
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.